Erlotinib Tablet, Film Coated
Product Images NDC 59651-532

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Erlotinib (NDC 59651-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Erlotinib-fig1 (Erlotinib Fig1)

A progression-free survival Kaplan-Meier curve comparing Erlotinib and chemotherapy over time in months. The y-axis shows progression-free survival probability, ranging from 0 to 1. The x-axis shows duration of progression-free survival in months, up to 45 months. The graph includes numbers of patients at risk for both treatment groups at different time points.*

FDA Label Image

Package Label-principal Display Panel (150 mg (30 Tablets Carton))

Packaging label for Erlotinib Tablets 150 mg film-coated tablets by Aurobindo Pharma Limited. The box contains 10 unit-dose tablets (1 x 10) and displays storage instructions, NDC 59651-532-10, and distributor information for Aurobindo Pharma USA, Inc., East Windsor, NJ. The label states the product is Rx only and made in India.*

FDA Label Image

Erlotinib-fig2 (Erlotinib Fig2)

A Kaplan-Meier survival curve comparing overall survival probabilities over months for patients treated with Erlotinib versus a placebo. The plot shows survival probability on the vertical axis and overall survival in months on the horizontal axis. Below the graph, a table lists the number of patients at risk for each group at various time points up to 36 months.*

FDA Label Image

Erlotinib-fig3 (Erlotinib Fig3)

A Kaplan-Meier survival curve chart showing overall survival probability over time in months for patients treated with Erlotinib compared to Placebo. The graph includes survival probability on the vertical axis and overall survival in months on the horizontal axis, with a table below indicating the number of patients at risk for each treatment group at various time points.*

FDA Label Image

Erlotinib-fig4 (Erlotinib Fig4)

A survival curve chart displaying overall survival probability over time in months, comparing Erlotinib with placebo. The x-axis represents overall survival in months, and the y-axis shows survival probability from 0 to 1. Two curves compare patient groups for Erlotinib and placebo, with a table below indicating the number of patients at risk at various time points for each group.*

FDA Label Image

Package Label-principal Display Panel (25 mg (30 Tablets Bottle))

Label for Erlotinib Tablets 25 mg, film-coated oral tablets, with a package count of 30 tablets. The label displays the NDC number 59651-530-03 and indicates the product is distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions and mentions that each tablet contains 25 mg of erlotinib free base. The product is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (25 mg (30 Tablets Carton))

Packaging label for Erlotinib Tablets 25 mg film-coated oral tablets. The carton contains 10 unit-dose tablets (1 blister pack of 10 tablets) and is labeled Rx only. Distributed by Aurobindo Pharma USA, Inc., made in India. Includes storage instructions and barcode on label.*

FDA Label Image

Package Label.principal Display Panel- 100 mg (30 Tablets Bottle) (Erlotinib Fig7)

Label for Erlotinib Tablets 100 mg, film-coated oral tablets. The label states each tablet contains 100 mg erlotinib free base. It includes storage instructions, the distributor Aurobindo Pharma USA, Inc. in New Jersey, and that the product is made in India by Aurobindo Pharma Limited. The label also mentions a package size of 30 tablets with the NDC 59651-531-03 and a barcode.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablets Carton))

Packaging label for Erlotinib Tablets 100 mg film-coated oral tablets by Aurobindo Pharma Limited. The label shows a unit-dose package containing 10 tablets (1 x 10), with storage instructions and a barcode. It is marked Rx only and includes distributor Aurobindo Pharma USA, Inc. details.*

FDA Label Image

Package Label.principal Display Panel- 150 mg (30 Tablets Bottle) (Erlotinib Fig9)

Label for Erlotinib tablets 150 mg, film-coated oral tablets. The label indicates the product contains 30 tablets, with the active ingredient dose of 150 mg erlotinib free base per tablet. Distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and NDC number 59651-532-03 are also shown.*

FDA Label Image

Chemical Structure (Erlotinib Str)

Chemical structure of Erlotinib hydrochloride depicted in a molecular diagram showing its chemical bonds and components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.